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Background: The location and the number of lumbar sympathetic ganglia (LSG) vary between individuals. 
The aim of this study was to determine the appropriate level for a lumbar sympathetic ganglion block (LSGB), 
corresponding to the level at which the LSG principally aggregate.
Methods: Seventy-four consecutive subjects, including 31 women and 31 men, underwent LSGB either on 
the left (n = 31) or the right side (n = 43). The primary site of needle entry was randomly selected at the 
L3 or L4 vertebra. A total of less than 1 ml of radio opaque dye with 4% lidocaine was injected, taking caution 
not to traverse beyond the level of one vertebral body. The procedure was considered responsive when the skin 
temperature increased by more than 1oC within 5 minutes.
Results: The median responsive level was significantly different between the left (lower third of the L4 body) 
and right (lower margin of the L3 body) sides (P = 0.021). However, there was no significant difference in 
the values between men and women. The overall median responsive level was the upper third of the L4 body. 
The mean responsive level did not correlate with height or BMI. There were no complications on short-term 
follow-up.
Conclusions: Selection of the primary target in the left lower third of the L4 vertebral body and the right 
lower margin of the L3 vertebral body may reduce the number of needle insertions and the volume of agents 
used in conventional or neurolytic LSGB and radiofrequency thermocoagulation. (Korean J Pain 2016; 29: 
103-9)
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INTRODUCTION
Lumbar sympathetic ganglion block (LSGB) and neu-
rolysis have been used for more than 80 years to manage 
patients with sympathetically maintained pain such as 
complex regional pain syndrome, vascular disease, and 
hyperhidrosis of the lower extremity [1]. Although it has 
been considered a safe procedure, an accurate knowledge 
of the relationship between the lumbar sympathetic chain 
and ganglia and the vertebral bodies is needed to success-
fully perform the procedure and to avoid complications 
[2,3]. 
In the clinical setting, the lumbar sympathetic ganglia 
(LSG) are commonly blocked between vertebral levels L2 
and L4. In contrast to the thoracic sympathetic ganglia, 
the location and number of the LSG are variable. 
Therefore, to obtain complete sympatholytic effect, per-
forming a multi-level LSGB appears to be more beneficial 
than performing a single-level LSGB [3,4]. However, mul-
ti-level LSGB can lead to complications, including lumbar 
nerve neuralgia, subarachnoid injection, and perforation of 
the aorta, inferior vena cava, bowel, lower pole of the kid-
ney, and ureter, and may cause patient discomfort [4-6].
Cadaveric studies have demonstrated that an average 
of 3 ganglia aggregate between the lumbar vertebral levels 
from the lower third of the L2 vertebral body to the upper 
third of the L3 vertebral body, and this site is most com-
monly identified anterior to the L2/3 intervertebral disc [7]. 
It was also noted that the lumbar arteries traversed the 
middle of the L2 and L3 vertebrae. The use of at least 2 
needles at the levels of the L2 and L3 vertebral bodies was 
favored by those authors. In another cadaveric study, 
Datta and Pai [3] reported that the ganglia are located at 
each level of the intervertebral discs or just paradiscal, and 
away from the lumbar vessels at this point. The results 
of a study by Rocco et al. [8] were also consistent, indicat-
ing that the LSG were most often present at the level of 
the L2/3 and L3/4 intervertebral disc spaces, suggesting 
that the needle should be approached slightly cephalad to 
the midpoint of the body of L3.
In clinical settings, the sympathetic function is always 
evaluated after sympathetic blocks. Assessing changes in 
skin temperature or sweating of the foot is a simple meth-
od to evaluate a successful sympathetic block [9]. A pre-
vious clinical study to investigate the appropriate block 
level for LSGB demonstrated that spreading local anes-
thetics from the lower half of the L4 vertebral body to the 
L4/5 interspace was most effective, and assumed this was 
where the LSG aggregated [10]. However in this study, a 
total of 3 ml of agents were utilized, followed by the spread 
of the agents which extended across 2 or more vertebral 
body levels. This resulted in difficulty of assessing the pre-
cise location of the LSG. Therefore, the authors designed 
a new clinical study to determine the precise lumbar verte-
bral level where the LSG principally aggregate. 
MATERIALS AND METHODS
This retrospective study was approved by the Institu-
tional Review Board and ethics committee of Gangnam 
Severance Hospital. Written informed consent was ob-
tained from each patient prior to the procedure. All cases 
of LSGB between January 2012 and January 2015 were re-
viewed in our Pain Clinic. The exclusion criteria were as 
follows: cases without a detailed description of the proce-
dure, fluoroscopic findings or results of LSGB; diseases 
that are associated with a minimal temperature change, 
even with a successful blockade, such as peripheral artery 
occlusive disease [11]. 
Intravenous hydration with 500 ml of normal saline or 
Hartmann’s solution was applied before the procedure. The 
patients were placed in the prone or lateral position on a 
radiology table. Temperature probes (Marquette, GE medi-
cal systems; Wisconsin, USA) for real-time temperature 
monitoring were attached to the soles of both feet [12,13]. 
The primary site of needle entry was randomly se-
lected at the L3 or L4 vertebra. The skin was prepared 
and draped in a sterile fashion. The spinous process of the 
L3 or L4 vertebra was identified using a fluoroscope in an 
antero-posterior (AP) projection. Then, the fluoroscope 
was rotated to a 25o oblique angle toward the correspond-
ing side. The skin entry point was identified at the lateral 
edge of the vertebral body, and a local anesthetic infiltra-
tion was introduced. A 22-gauge, short bevel needle was 
advanced to the lateral margin of the vertebral body by 
means of a “tunnel vision technique” under fluoroscopic 
guidance [6,14]. When the needle touched the L3 or L4 
vertebral body, the fluoroscope was rotated to a lateral 
projection, and the needle was advanced until the needle 
tip was just behind the anterior edge of the vertebral body. 
At this stage, the needle tip should lie on the anterolateral 
part of the vertebral body and appear to be just outside 
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Fig. 1. Fluoroscopic view of 
LSGB. (A) Anteroposterior 
fluoroscopic view of the level
of spread of the dye. (B) 
Lateral view of the level of 
spread of the dye. In this 
case, A and B demonstrate 
that the longitudinal dye 
spread is from point 5.5 to 
7.5 on the numerical scale 
(see Fig. 2).
Fig. 2. The space between upper border of sacrum and 
upper border of L2 vertebral body were divided into 16 
segments to allow numerical description of the dye spread. 
the facetal line on the AP projection (Fig. 1). 
When the needle tip approached the target site, the 
upper or lower third of the vertebral body, aspiration was 
performed to check for bleeding. Less than 1 ml of a mix-
ture of radio opaque dye (BonorexⓇ, 300 mgl/ml; CMS, 
Korea) and the same volume of 4% lidocaine was injected, 
taking care not to traverse one vertebral body level. The 
procedure was considered responsive when the skin tem-
perature increased by more than 1oC within 5 minutes 
[9,10]. When the first procedure was determined as un-
responsive, the second one was repeated at the next ver-
tebral level sequentially. Additionally, when radio opaque 
dye was observed in the psoas muscle or blood vessels, 
the procedure was repeated at another vertebral level.
The height of the lumbar vertebral column was sub-
divided as follows; upper, medium, and lower lumbar body 
and lumbar intervertebral disc segment. The space be-
tween the upper border of the sacrum (point 0) to the up-
per border of the L2 vertebra (point 16) was divided into 
16 segments to allow numerical description of the spread 
of the dye (Fig. 2).
Statistical analyses were performed with the Statistical 
Package for the Social Sciences 21.0 (SPSS Inc., Chicago, 
IL, USA). All data are expressed as median (Q1-Q3) or as 
the number of patients. Normality tests were performed 
using Kolmogorov-Smirnov tests. Comparison of the dem-
ographic data between the groups was performed using 
the Mann-Whitney test. For inter-group comparisons, the 
Mann-Whitney test was used to compare the mean values 
of the spread level of the dye for nonparametric descriptive 
data. A P value ＜ 0.05 was considered statistically 
significant.
RESULTS
Demographic data for the 74 subjects enrolled in the 
study are listed in Table 1. Of the 74 consecutive subjects 
(31 men and 31 women) aged 20-83 years, 31 and 43 sub-
jects were treated with LSGB on the left and the right side, 
respectively. LSGB was performed at the L3 and L4 verte-
brae in 34 and 40 subjects, respectively. Seventeen sub-
jects with LSGB at L3 and 13 with LSGB at L4 required 
an additional blockade at the next vertebral levels due to 
the lack of a response. 
There were 29 subjects with hyperhidrosis, 14 with 
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Table 1. Demographic Data
Age (yrs) Height (cm) Weight (kg)
Sex
  M (n = 31) 39 (23−62) 168.8 (165−173)   65 (57−75.5)
  F (n = 31) 48 (32−64)       159 (154.5−161.1)*    52 (46−57.5)*
Site
  Left (s = 31) 39 (24−63) 161.1 (158−169) 57 (47−66)
  Right (s = 43) 48 (26−63)  165 (160−170) 57 (48−73)
Level
  L3 (s = 34) 52.5 (31−68.3)    163.5 (158.3−168.9) 57.5 (47.8−73)
  L4 (s = 40) 39 (24−61) 162.4 (158−171) 57 (47−70)
Total (s = 74)    50 (47.8−75.8) 162.7 (158−170)    57 (47.8−70.8)
The values are expressed as the median (Q1−Q3). n: number of patients. s: number of subjects. *P ＜ 0.05 compared to male group.
Fig. 3. The mean responsive level in male and female 
patients. The boxes are expressed as the median (Q1−Q3).
Fig. 4. The mean responsive level in left- and right-sided 
LSGB. The boxes are expressed as the median (Q1−Q3).
lumbar postlaminectomy syndrome, 12 with lumbosacral 
spinal stenosis, 9 with complex regional pain syndrome 
(CRPS), 5 with autonomic nervous system disorder, 4 with 
Raynaud's disease, and 2 with frostbite. 
In male patients, the mean level at which a response 
was achieved according to the numeric scales was between 
5.6 (lower third of the L4 body) and 9.5 (lower third of the 
L3 body), with a median value of 6.5 (upper margin of the 
L4 body). In female patients, the values were between 6 
(middle third of the L4 body) and 9.7 (lower third of the 
L3 body) with a median value of 8 (upper margin of the 
L4 body). Although there seemed to be a tendency of a 
higher median spread of the dye level in female patients 
compared to male patients, there was no statistically sig-
nificant difference between the two groups due to the sim-
ilar distribution pattern of the mean responsive level (P = 
0.251) (Fig. 3). 
In the right LSGB group, the mean responsive level on 
the numerical scale was between 6 (middle third of the L4 
body) and 10 (middle third of the L3 body), with a median 
value of 9 (lower margin of the L3 body). In the left LSGB 
group, the values were between 5.5 (lower third of the L4 
body) and 9.3 (lower third of the L3 body) with a median 
value of 6 (lower third of the L4 body) (Fig. 4). The differ-
ence was statistically significant between the two groups 
(P = 0.021). Among the enrolled patients, the median re-
sponsive level was the upper third of the L4 body.
There were statistically significant differences in 
height, weight, and BMI between the male and female 
patients. However the mean responsive level did not corre-
late with height, weight, or BMI.
There were no complications during the short-term 
follow-up, and the study was successfully completed in all 
patients.
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DISCUSSION
The lumbar sympathetic ganglia lie in the anterolateral 
aspect of the L2, L3, and L4 vertebral bodies and anterior 
to the psoas muscle [8]. An LSGB using a chemical neuro-
lytic agent requires the spreading of the agent into the 
retroperitoneal compartment, which is surrounded by the 
anterior angle of the psoas muscle and the anterolateral 
plane of the vertebral body. It is important to ensure that 
the agent does not spread toward the ureter, backward in-
to the psoas muscle, or into blood vessels. When the 
spread of the dye and the rise in skin temperature both 
indicated an effective block without complications, the 
same volume of dehydrated alcohol was injected to chemi-
cally degenerate the sympathetic ganglion.
In single-needle LSGBs with large volumes (＞5 ml), 
which have been performed in an earlier era, the tip of 
the needle did not necessarily need to be close to the gan-
glion because the injected solution would sufficiently 
spread along the sympathetic chain [4,15]. However, with 
the injection of larger volumes, there is an increase in the 
frequency of complications, including motor weakness, 
genitofemoral neuritis, lumbar neuralgia, and somatic 
nerve blockade, especially when neurolytic agents are used 
[5,11]. By placing the tip of the needle in close proximity 
to the ganglion, an LSGB can be performed with only a 
small amount of neurolytic solution and thus with little or 
no spread to adjacent structures.
In the past, the LSG was assumed to be most fre-
quently located at the level of the intervertebral disc of L2 
and L3 on both the right and left sides [7]. However, Kim 
et al. [10] reported that the LSG is located in the lower 
third of the L4 vertebra in patients with plantar hyper-
hidrosis or pain pathology of the lower extremities. This 
finding corresponds to the connection of foot lesions to the 
lower LSG [16]. 
Sayson et al. [11] reported that the incidence of genito-
femoral nerve blocks after LSGB is greater at L4 (40%) 
than at L2 (0%). Feigl et al. [17] reported that there is a 
greater likeliness that the genitofemoral nerve will be lo-
cated at the L3/4 and L4/5 levels than at the L2/3 level, 
based on a cadaveric study. Anatomically, the genito-
femoral nerve approached the medial margin of the psoas 
major muscle and passed the lumbar sympathetic trunk 
[17]. This is thought to be one of the explanations for the 
lower incidence of psoas muscle injection during LSGBs at 
L2 compared with injections at the L3 and L4 vertebral 
levels [18].
On the other hand, an LSGB at the L2 vertebral level 
increases the potential risk of kidney and ureter injury 
compared with an LSGB at the L3 level due to the shorter 
distance from the spinous process of the L2 vertebra 
[5,19]. At a 10 cm distance from the spinous process at 
the L2 level, the rate of renal puncture was 57.5% [5]. 
Ureter injury from neurolytic agents during LSGBs has also 
been reported [20]. In addition, ureter necrosis is reported 
to be a serious complication in chemically induced LSGBs 
at the L2 vertebral level [21]. Ejaculatory dysfunction was 
also reported after neurolytic an LSGB at the L2 level due 
to the spread of agents into the thoraco-lumbar sym-
pathetic chain (T11-L2) [22]. In a study comparing RF lum-
bar sympatholysis with neurolytic LSGBs at the L3 level, 
although not significantly different statistically, the suc-
cess rates were 78% and 89%, respectively. While there 
were no complications reported in patients that received 
RF thermocoagulation, the relatively high proportion of 
complications and the occurrence of serious complications 
such as ejaculation failure is thought to be due to the large 
injection volume of the neurolytic agent [23]. 
Investigation of the location of the major vessels dem-
onstrated that the shortest distance was found at the right 
side of L3, compared to the left side of L3 and L2 [24]. 
Middleton and Chan [5] reported that puncture of the in-
ferior vena cava in right-sided LSGBs occurred in 20% of 
patients. Another study reported that the incidence of in-
travascular injection during LSGBs was not significantly 
different when the procedures were performed at the L2, 
L3, and L4 vertebral levels [18]. There is a possibility of 
retrograde ejaculatory failure in LSGBs performed at the 
L5 vertebral level [25]. Because the LSG at the L5 vertebral 
level is anatomically in close proximity to the superior hy-
pogastric plexus which coordinates bladder sphincter con-
trol during ejaculation.
Several studies of lumbar sympathetic radiofrequency 
(RF) lesioning have been performed at the L2, L3, and L4 
vertebral levels [23,26-28]. Compared to neurolytic LSGBs, 
in which the agent spreads to at least one or more verte-
bral body level, lumbar sympathetic RF thermocoagulation 
will only coagulate a small area surrounding the active 
portion of the RF needle tip. Hence, RF thermocoagulation 
is considered safe but less effective in terms of the success 
rate compared to neurolytic LSGBs. A single RF needle 
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produced lesions with short diameters which were 4 to 5 
times the needle diameter and long diameters the length 
of the active tip. And so 2 or 3 lesions were made at each 
vertebral level of L2, L3, and L4 in these studies. 
An investigational in vitro study with porcine spinal 
tissue demonstrated development of a sufficient, wider and 
longer lesion with RF thermocoagulation utilizing 2 needles 
[29]. Bipolar probes have been introduced clinically in ac-
cordance with the development of engineering techniques 
and made it possible to reduce the number of needle in-
sertion and produce longer and larger linear lesions in RF 
thermocoagulation [30]. These bipolar probes had over-
come the shortcomings of conventional lumbar sym-
pathetic RF lesioning in the upper and lower third of a sin-
gle vertebral body. Although this dual needle placement 
method led to successful results in terms of patient sat-
isfaction, multiple needle placements can lead to more 
complications, such as unnecessary lesioning of adjacent 
structures and patient discomfort [31]. Therefore, assess-
ing the precise location of the LSG and placing the needle 
tip in close proximity to the ganglia is even more important 
in RF lesioning. 
Anatomically, lumbar arteries inevitably cross the 
sympathetic chain, which runs vertically along the verte-
bral column at the middle portion of each vertebral body. 
Lumbar arteries were observed to cross the sympathetic 
chain at the level of the middle third of each vertebral body 
in cadaveric studies [7,8]. Recognition of the crossing point 
of the lumbar arteries and sympathetic chain is clinically 
important to avoid arterial puncture, since injury of these 
arteries may result in massive retroperitoneal hemorrhage, 
and injection of neurolytics into these arteries may cause 
neurologic sequelae due to vasospasm and/or spinal cord 
infarction [32,33].
Based on these previous studies, we chose the block 
level at the L3 and L4 vertebrae, and the volume of neuro-
lytic agent was reduced to less than 1 ml, taking care not 
to traverse one vertebral body level with an intent to de-
crease complications. However, this study has several 
limitations. First, the results did not present a normal dis-
tribution, and the limited number of patients were un-
equally distributed among specific disease groups. If the 
volume of agents is further reduced and injected with cau-
tion not to traverse two numeric scale levels, the results 
are anticipated to present a normal distribution. Second, 
we enrolled patients with a significant rise in skin temper-
ature without considering improvement of pain scores. A 
LSGB is performed to manage sympathetically maintained 
pain. Cutaneous toe temperatures approaching core tem-
perature, provides a useful monitor of a lumbar sym-
pathetic block and may predict relief of sympathetically 
maintained pain [13]. However, a successful LSGB does not 
always indicate improvement of pain and vice versa. Third, 
because the agents were injected with caution taken not 
to traverse one vertebral body level at the L3 and L4 ver-
tebral levels, the spread of the dye did not extend beyond 
L2, and thus our results were not comparable to those of 
previous studies that insisted that the LSG aggregated at 
the level of the L2/3 intervertebral disc [3]. In addition, 
further study is required to investigate the relationship be-
tween destructive LSGBs and the long-term outcomes and 
to determine the shape and size of the lesions produced 
in lumbar sympathetic RF thermocoagulation in humans.
In conclusion, this study demonstrates that the LSG 
presumably aggregate at a lower level (lower third of L4) 
in left-sided LSGBs than in right-sided LSGBs (lower mar-
gin of L3). There was no significant difference in the 
spread of dye between men and women. The results may 
be useful to better select the primary target when per-
forming LSGBs, thus reducing the volume of the agent 
used in conventional and neurolytic LSGBs and decreasing 
the number of needle insertions performed in LSGBs or ra-
diofrequency thermocoagulation.
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